Lyra Therapeutics Inc. (LYRA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
5:10 pm
Purchase
2020-12-3113GLyra Therapeutics, Inc.
LYRA
Polaris Venture Partners V, L.P.28,475
11.000%
28,475increase
(New Position)
Filing
History
2021-02-12
4:16 pm
Purchase
2020-12-3113GLyra Therapeutics, Inc.
LYRA
INTERSOUTH PARTNERS VII L P14,764
5.700%
14,764increase
(New Position)
Filing
History
2020-12-30
5:26 pm
Purchase
2020-12-1513GLyra Therapeutics, Inc.
LYRA
Ikarian Capital, LLC15,707
6.100%
15,707increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2